{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Connect Ovar Coffee","title":"Dr. Alexander Olawaiye: Inside Platinum Resistant Ovarian Cancer - Actions & Insights","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/3ffb5910\"></iframe>","width":"100%","height":180,"duration":3719,"description":"Connect Ovar Coffee: Dr. Alexander OlawaiyeThis episode features Dr. Alexander Olawaiye, discussing major advances in ovarian cancer treatment, including the ROSELLA clinical trial.\n \n Key Highlights:\n1. Ovarian Cancer Challenges:\n- No reliable early screening methods\n- Majority diagnosed at advanced stages (Stage III/IV)\n- Early detection remains a critical unmet need\n2. ROSELLA Trial Breakthrough:\n- Focus on platinum-resistant ovarian cancer\n- Combines relacorilant (a glucocorticoid receptor antagonist) with nab-paclitaxel\n- Demonstrated improved progression-free survival and overall survival\n- No biomarker requirement, making it accessible to more patients\n3. Mechanism of Action:\n- Relacorilant blocks cortisol signaling that promotes chemotherapy resistance\n- Enhances effectiveness of chemotherapy\n4. Safety & Tolerability:\n- No new major toxicities identified\n- Side effects consistent with standard chemotherapy\n5. Clinical Trial Importance:\n- Patients in trials often experience better outcomes\n- Participation helps advance future treatments\n6. Health Equity & Access:\n- Disparities exist in access to care and clinical trials\n- Need to improve awareness, access, and inclusion\n7. Future Outlook:\n- Rapid growth in new treatments over past decade\n- Emerging therapies include antibody-drug conjugates\n- Continued innovation offers hope for patients\n\n Closing Message:\nStay informed, consider clinical trials, and remain hopeful as new treatments continue to emerge.\n ","thumbnail_url":"https://img.transistorcdn.com/qnZmNf9dzwooWpgatp0KKSgixcBg00e4S6NWRySHasM/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzI3NDExLzE2NDE5/NDM5NTUtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}